Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Depressed woman with head in hands

UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety

The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...

10x Genomics Graduates from ‘Super Success’ to $100M IPO

10x Genomics has disclosed plans to raise $100 million through an initial public offering, according to a registration statement filed with the U.S. Securities...

Five-Year Super Successes in Genomics and Precision Medicine

Multidimensional, computationally rich approaches represent the next wave of innovation, taking personalized medicine to the next level, while demanding more of practitioners, who in...
DNA Sequence

EMBL-EBI Launches Free Genetic Disease Diagnostic Software

Researchers at the University of Edinburgh and the European Bioinformatics Institute at the European Molecular Biology Laboratory (EMBL-EBI) have introduced a new diagnostic genome-wide...
Scientist holding a DNA sample with the results on a computer sceeen in a laboratory

Invitae Offers Free Genetic Testing for Four Conditions

Invitae said it is offering for free its Detect genetic testing programs for four conditions: Muscular dystrophy, hereditary prostate cancer, familial cardiomyopathy and arrhythmia,...
Smiling Beagle

Are Dogs the New Early Cancer Detection Tool?

A dog’s sense of smell—more than 10,000 times more sensitive than that of our own—has been exploited by humans for centuries. Whether it is...
The American Association of Clinical Urologists (AACU) has issued a position statement encouraging the use of tissue-based molecular testing and/or germline testing for three groups of prostate cancer patients. [Ji-Xin Cheng

Clinical Urologists Group Supports Genomic Testing for Prostate Cancer

AACU statement encourages use of tissue-based molecular testing and/or germline testing for three groups of prostate cancer patients
A doctor taking a patient's blood sample

Liquid Biopsy Equal to Tissue to Indicate Immunotherapy Response

Liquid biopsy is just as good as traditional tumor testing at identifying microsatellite instability (MSI), an important biomarker used to predict response to immunotherapy...

Former Foundation Medicine Execs Join Hopkins Kimmel Directors, VCs in New Company

Steven Kafka, Ph.D., the former president and chief operating officer of Foundation Medicine who left the company last year, has joined with former colleagues...
Scroll Up